• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchGossamer Bio
    Picture of Gossamer Bio logo

    GOSS — Gossamer Bio News Story

    $9.610.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    • Market Cap
      $58.75m
    • Enterprise Value
      $37.87m
    • Revenue
      $48.47m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • GOSS Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    GOSS Dividends
    All News

    NASDAQ RESUMED AT 08:35 AM

    Picture of Gossamer Bio logoGossamer Bio
    23/02/2026 13:35
    NASDAQ RESUMED  GOSS.O  AT 08:35 AM
    

    Recent news on Gossamer Bio

    See all news
    • Brief: Gossamer Bio Submits New Drug Application To US FDA For Seralutinib For The Treatment Of Pulmonary Arterial Hypertension

      23/09/2026 22:07
    • NASDAQ RESUMED AT 09:00 AM

      11/09/2026 14:00
    • NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM

      11/09/2026 08:58
    • NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM

      11/09/2026 24:50
    • Brief: Gossamer Bio - Board Approves Amendment And Restatement Of Bylaws Effective Sept 3, 2026 - SEC Filing

      03/09/2026 22:38

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.